gnckКолопроктологияKoloproktologia2073-75562686-7303Russian Association of Coloproctology10.33878/2073-7556-2023-22-4-129-134gnck-1866Research ArticleОБЗОРЫ ЛИТЕРАТУРЫ И МЕТААНАЛИЗLITERATURE REVIEWS AND METAANALYSISПроблемы предоперационной диагностики поражения тазовых лимфоузлов при раке прямой кишки (обзор литературы)Problems of preoperative diagnosis of pelvic lymph node lesions in rectal cancer (review)https://orcid.org/0000-0001-5655-6567АлексеевМ. В.AlekseevM. V.

Алексеев М.В. — д.м.н., заведующий отделением онкопроктологии, доцент кафедры колопроктологии, ул. Саляма Адиля, д. 2, г. Москва, 123423;

ул. Баррикадная, д. 2/1, г. Москва, 125993

Michail V. Alekseev - Salyama Adilya st., 2, Moscow, 123423;

Barrikadnaya st., 2/1-1, Moscow, 125993

doctor-pro@mail.ruhttps://orcid.org/0000-0002-3399-0608ХомяковЕ. А.KhomyakovE. A.

Хомяков Е.А. — к.м.н., научный сотрудник, ассистент кафедры колопроктологии, ул. Саляма Адиля, д. 2, г. Москва, 123423;

ул. Баррикадная, д. 2/1, г. Москва, 125993

Evgeniy A. Khomyakov - Salyama Adilya st., 2, Moscow, 123423;

Barrikadnaya st., 2/1-1, Moscow, 125993

https://orcid.org/0000-0002-3919-9067РыбаковЕ. Г.RybakovE. G.

Рыбаков Е.Г. — д.м.н., профессор РАН, руководитель отдела онкопроктологии,

ул. Саляма Адиля, д. 2, г. Москва, 123423

Evgeny G. Rybakov,

Salyama Adilya st., 2, Moscow, 123423

ФГБУ «НМИЦ колопроктологии имени А.Н. Рыжих» Минздрава России; ФГБОУ РМАНПО Минздрава РоссииРоссияRyzhikh National Medical Research Center of Coloproctology; Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare of RussiaRussian FederationФГБУ «НМИЦ колопроктологии имени А.Н. Рыжих» Минздрава РоссииРоссияRyzhikh National Medical Research Center of ColoproctologyRussian Federation202321122023224129134Copyright © Алексеев М.В., Хомяков Е.А., Рыбаков Е.Г., 20232023Алексеев М.В., Хомяков Е.А., Рыбаков Е.Г.Alekseev M.V., Khomyakov E.A., Rybakov E.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.ruproctology.com/jour/article/view/1866Введение

Введение: метастатически пораженные латеральные тазовые лимфоузлы (ЛТЛУ) выявляются у 6–15% больных раком средне- и нижнеампулярного отделов прямой кишки. Надежные критерии, по которым можно было бы с уверенностью судить о метастатическом поражении ЛТЛУ, отсутствуют. Общепринятой тактики лечения пациентов с наличием увеличенных ЛТЛУ в настоящий момент не существует.

Цель

Цель: систематизация имеющихся литературных источников по латеральной тазовой лимфодиссекции у пациентов с раком прямой кишки и оценка современного состояния проблемы.

Материалы и методы

Материалы и методы: поиск литературы проводился в электронной базе PubMed по ключевым словам: LLND, lateral lymph node, rectal cancer, lymphodissection. Поиск работ на русском языке был осуществлен в отечественной электронной библиотеке E-library по запросу: латеральная лимфодиссекция, тазовая лимфодиссекция, рак прямой кишки, латеральные и тазовые лимфатические узлы. Дополнительные источники были найдены по перекрестным ссылкам литературы. Дата поиска — июль 2023.

Результаты

Результаты: предоперационная ХЛТ с мезоректумэктомией, дополненной селективной ЛТЛД при подозрении на наличие метастазов выглядит рациональной стратегией для достижения благоприятного онкологического результата лечения.

Заключение

Заключение: для разработки однозначных рекомендаций и выводов, требуется проведение дополнительных исследований.

Background

Background: metastasis in lateral pelvic lymph nodes (LPLN) occurred in 6–15% of patients with middle or low rectal cancer. Currently there are still no criteria of diagnosis of this. There is no generally accepted management this group of the patients.

Aim

Aim: to systematize the available literature data about lateral pelvic lymph node dissection in patients with rectal cancer.

Materials and Methods

Materials and Methods: literature search was performed in the PubMed and e-Library databases using the keywords: LLND, lateral lymph node, rectal cancer, lymphodissection. The search date: July 2023.

Results

Results: preoperative CRT with total mesorectumectomy supplemented with selective LTLD for suspected metastases seems to be a rational strategy to achieve a favorable oncological treatment outcome.

Conclusion

Conclusion: Additional studies are required.

латеральная тазовая лимфодиссекциярак прямой кишкилатеральные тазовые лимфатические узлыlateral pelvic lymph nodes dissectionrectal cancerlateral pelvic lymph nodesReferencesSugihara K, Kobayashi H, Kato T, et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum. 2006 Nov;49(11):1663–72. doi: 10.1007/s10350-006-0714-zSugihara K, Kobayashi H, Kato T, et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum. 2006 Nov;49(11):1663–72. doi: 10.1007/s10350-006-0714-zTakahashi T, Ueno M, Azekura K, et al. Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum. 2000 Oct;43(10 Suppl):S59–68. doi: 10.1007/BF02237228Takahashi T, Ueno M, Azekura K, et al. Lateral node dissection and total mesorectal excision for rectal cancer. Dis Colon Rectum. 2000 Oct;43(10 Suppl):S59–68. doi: 10.1007/BF02237228Torkzad MR, Påhlman L, Glimelius B. Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review. Insights Imaging. 2010 Sep;1(4):245–267. doi: 10.1007/s13244-010-0037-4Torkzad MR, Påhlman L, Glimelius B. Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review. Insights Imaging. 2010 Sep;1(4):245–267. doi: 10.1007/s13244-010-0037-4Hoshino N, Murakami K, Hida K, et al. Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer: a systematic review and meta-analysis. Int J Clin Oncol. 2019 Jan;24(1):46–52. doi: 10.1007/s10147-018-1349-5Hoshino N, Murakami K, Hida K, et al. Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer: a systematic review and meta-analysis. Int J Clin Oncol. 2019 Jan;24(1):46–52. doi: 10.1007/s10147-018-1349-5Klessen C, Rogalla P, Taupitz M. Local staging of rectal cancer: the current role of MRI. Eur Radiol. 2007 Feb;17(2):379–89. doi: 10.1007/s00330-006-0388-xKlessen C, Rogalla P, Taupitz M. Local staging of rectal cancer: the current role of MRI. Eur Radiol. 2007 Feb;17(2):379–89. doi: 10.1007/s00330-006-0388-xBrouwer NPM, Stijns RCH, Lemmens VEPP, et al. Clinical lymph node staging in colorectal cancer; a flip of the coin? Eur J Surg Oncol. 2018 Aug;44(8):1241–1246. doi: 10.1016/j.ejso.2018.04.008Brouwer NPM, Stijns RCH, Lemmens VEPP, et al. Clinical lymph node staging in colorectal cancer; a flip of the coin? Eur J Surg Oncol. 2018 Aug;44(8):1241–1246. doi: 10.1016/j.ejso.2018.04.008Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012 Jul;19(7):2212–23. doi: 10.1245/s10434-011-2210-5Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012 Jul;19(7):2212–23. doi: 10.1245/s10434-011-2210-5Yukimoto R, Uemura M, Tsuboyama T, et al. Efficacy of positron emission tomography in diagnosis of lateral lymph node metastases in patients with rectal Cancer: a retrospective study. BMC Cancer. 2021 May 8;21(1):520. doi: 10.1186/s12885-021-08278-6Yukimoto R, Uemura M, Tsuboyama T, et al. Efficacy of positron emission tomography in diagnosis of lateral lymph node metastases in patients with rectal Cancer: a retrospective study. BMC Cancer. 2021 May 8;21(1):520. doi: 10.1186/s12885-021-08278-6Ishihara S, Kawai K, Tanaka T, et al. Diagnostic value of FDGPET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Tech Coloproctol. 2018 May;22(5):347–354. doi: 10.1007/s10151-018-1779-0Ishihara S, Kawai K, Tanaka T, et al. Diagnostic value of FDGPET/CT for lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Tech Coloproctol. 2018 May;22(5):347–354. doi: 10.1007/s10151-018-1779-0Hashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020 Jan;25(1):1–42. doi: 10.1007/s10147-019-01485-zHashiguchi Y, Muro K, Saito Y, et al. Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020 Jan;25(1):1–42. doi: 10.1007/s10147-019-01485-zAmin MB, Edge S, Greene F. AJCC cancer staging manual. 8th ed. New York, Springer; 2017. doi: 10.1007/978-3-319-40618-3_48Amin MB, Edge S, Greene F. AJCC cancer staging manual. 8th ed. New York, Springer; 2017. doi: 10.1007/978-3-319-40618-3_48Sauer R, Becker H, Hohenberger W, et al. German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004 Oct 21;351(17):1731–40. doi: 10.1056/NEJMoa040694Sauer R, Becker H, Hohenberger W, et al. German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004 Oct 21;351(17):1731–40. doi: 10.1056/NEJMoa040694Ozawa H, Kotake K, Hosaka M, et al. Impact of Lateral Pelvic Lymph Node Dissection on the Survival of Patients with T3 and T4 Low Rectal Cancer. World J Surg. 2016 Jun;40(6):1492–9. doi: 10.1007/s00268-016-3444-yOzawa H, Kotake K, Hosaka M, et al. Impact of Lateral Pelvic Lymph Node Dissection on the Survival of Patients with T3 and T4 Low Rectal Cancer. World J Surg. 2016 Jun;40(6):1492–9. doi: 10.1007/s00268-016-3444-yKanemitsu Y, Komori K, Shida D, et al. Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: A comparison of 2 high-volume centers in Japan that employ different policies concerning LLND. Surgery. 2017 Aug;162(2):303–314. doi: 10.1016/j.surg.2017.02.005Kanemitsu Y, Komori K, Shida D, et al. Potential impact of lateral lymph node dissection (LLND) for low rectal cancer on prognoses and local control: A comparison of 2 high-volume centers in Japan that employ different policies concerning LLND. Surgery. 2017 Aug;162(2):303–314. doi: 10.1016/j.surg.2017.02.005Tsukamoto S, Fujita S, Ota M, et al. Colorectal Cancer Study Group of Japan Clinical Oncology Group. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212). Br J Surg. 2020 Apr;107(5):586–594. doi: 10.1002/bjs.11513Tsukamoto S, Fujita S, Ota M, et al. Colorectal Cancer Study Group of Japan Clinical Oncology Group. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212). Br J Surg. 2020 Apr;107(5):586–594. doi: 10.1002/bjs.11513Kusters M, Beets GL, van de Velde CJ, et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg. 2009 Feb;249(2):229–35. doi: 10.1097/SLA.0b013e318190a664Kusters M, Beets GL, van de Velde CJ, et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg. 2009 Feb;249(2):229–35. doi: 10.1097/SLA.0b013e318190a664Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol. 2009 Nov;10(11):1053–62. doi: 10.1016/S1470-2045(09)70224-4Georgiou P, Tan E, Gouvas N, et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol. 2009 Nov;10(11):1053–62. doi: 10.1016/S1470-2045(09)70224-4Fujita S, Mizusawa J, Kanemitsu Y, et al. Colorectal Cancer Study Group of Japan Clinical Oncology Group. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/ III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. Ann Surg. 2017 Aug;266(2):201– 207. doi: 10.1097/SLA.0000000000002212Fujita S, Mizusawa J, Kanemitsu Y, et al. Colorectal Cancer Study Group of Japan Clinical Oncology Group. Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/ III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial. Ann Surg. 2017 Aug;266(2):201– 207. doi: 10.1097/SLA.0000000000002212Hatano S, Ishida H, Ishiguro T, et al. Prediction of metastasis to mesorectal, internal iliac and obturator lymph nodes according to size criteria in patients with locally advanced lower rectal cancer. Jpn J Clin Oncol. 2015 Jan;45(1):35–42. doi: 10.1093/jjco/hyu162Hatano S, Ishida H, Ishiguro T, et al. Prediction of metastasis to mesorectal, internal iliac and obturator lymph nodes according to size criteria in patients with locally advanced lower rectal cancer. Jpn J Clin Oncol. 2015 Jan;45(1):35–42. doi: 10.1093/jjco/hyu162Akiyoshi T, Matsueda K, Hiratsuka M, et al. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S614–20. doi: 10.1245/s10434-015-4565-5Akiyoshi T, Matsueda K, Hiratsuka M, et al. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S614–20. doi: 10.1245/s10434-015-4565-5Lim SB, Yu CS, Kim CW, et al. Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy. Int J Colorectal Dis. 2013 Dec;28(12):1667–74. doi: 10.1007/s00384-013- 1761-2Lim SB, Yu CS, Kim CW, et al. Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy. Int J Colorectal Dis. 2013 Dec;28(12):1667–74. doi: 10.1007/s00384-013- 1761-2Oh HK, Kang SB, Lee SM, et al. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol. 2014 Jul;21(7):2280–7. doi: 10.1245/s10434-014-3559-zOh HK, Kang SB, Lee SM, et al. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study. Ann Surg Oncol. 2014 Jul;21(7):2280–7. doi: 10.1245/s10434-014-3559-zWatanabe J, Ohya H, Sakai J, et al. Long-term outcomes of indocyanine green fluorescence imaging-guided laparoscopic lateral pelvic lymph node dissection for clinical stage II/III middle-lower rectal cancer: a propensity score-matched cohort study. Tech Coloproctol. 2023 Sep;27(9):759–767. doi: 10.1007/s10151-023-02761-xWatanabe J, Ohya H, Sakai J, et al. Long-term outcomes of indocyanine green fluorescence imaging-guided laparoscopic lateral pelvic lymph node dissection for clinical stage II/III middle-lower rectal cancer: a propensity score-matched cohort study. Tech Coloproctol. 2023 Sep;27(9):759–767. doi: 10.1007/s10151-023-02761-xMa L, Wang J, Kiyomatsu H, et al. Surgical navigation system for laparoscopic lateral pelvic lymph node dissection in rectal cancer surgery using laparoscopic-vision-tracked ultrasonic imaging. Surg Endosc. 2021 Dec;35(12):6556–6567. doi: 10.1007/s00464-020-08153-8Ma L, Wang J, Kiyomatsu H, et al. Surgical navigation system for laparoscopic lateral pelvic lymph node dissection in rectal cancer surgery using laparoscopic-vision-tracked ultrasonic imaging. Surg Endosc. 2021 Dec;35(12):6556–6567. doi: 10.1007/s00464-020-08153-8

The authors declare that there are no conflicts of interest present.